Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications

Radiother Oncol. 2020 Nov:152:70-77. doi: 10.1016/j.radonc.2020.07.038. Epub 2020 Jul 25.

Abstract

Background and purpose: Substantial variation in the adoption of hypofractionation for breast radiation therapy has been observed, despite the availability of consensus guidelines. This study aimed to investigate the variation in radiation therapy fractionation in breast cancer patients in New South Wales (NSW), Australia, and to estimate survival outcome and cost implications.

Materials and methods: This is a population-based cohort of patients who received radiation therapy for breast cancer (2009-2013), as captured in the NSW Central Cancer Registry. A logistic regression model was used to identify factors associated with fractionation type. Survival outcome was estimated using multivariable Cox proportional hazards model. Cost per treatment and potential cost saving associated with evidence-based fractionation was estimated.

Results: A total of 10,482 patients were available for analysis, divided into 3 cohorts (breast alone: N = 7000; breast + nodes: N = 1119; all chestwall: N = 2363). In multivariable analysis, increasing age, laterality (right), year of treatment (2013), early stage, lower socioeconomic status, and regional area of residence were independent predictors of hypofractionation for breast alone radiation therapy. For the breast + nodes and chest wall cohorts, common factors that predicted the use of hypofractionation were increasing age. In multivariable survival analysis, there was no difference between the fractionation regimens at 5 years. Estimated radiation therapy cost of this cohort approximated $52.1 million, compared with $38.5 million had these patients been treated with evidence-based fractionation. This demonstrated a potential saving of $13.6 million.

Conclusion: Hypofractionation appears underused for breast radiation therapy in NSW over time. This study highlights that evidence-based practice will translate to reduced health care treatment costs.

Keywords: Breast cancer; Cost; Fractionation; Radiation therapy; Variation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Australia
  • Breast Neoplasms* / radiotherapy
  • Dose Fractionation, Radiation
  • Humans
  • New South Wales
  • Radiation Dose Hypofractionation
  • Radiotherapy, Adjuvant